Search
for
Sort by
Research 331–360 of 1000+
- Molecular genetics of androgen insensitivity
- Developmental origin of polycystic ovary syndrome - a hypothesis
- The Rotterdam Study: 2016 objectives and design update
- Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline
- Polycystic Ovary Syndrome
- Apoptosis in human skin development: Morphogenesis, periderm, and stem cells
- Development of polycystic ovary syndrome: involvement of genetic and environmental factors
- Bioengineering skin using mechanisms of regeneration and repair
- Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression
- Cutaneous Scarring: Basic Science, Current Treatments, and Future Directions
- Cutaneous complications of chemotherapeutic agents
- An Update of Congenital Adrenal Hyperplasia
- Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study
- Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development
- Adult polycystic ovary syndrome begins in childhood
- HAIR REGROWTH
- Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic
- Androgens and androgen receptor action in skin and hair follicles
- Polycystic Ovary Syndrome: Update on Diagnosis and Treatment
- Nutritional management in women with polycystic ovary syndrome: A review study
- Safety of testosterone treatment in postmenopausal women
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Ovarian Morphology Is a Marker of Heritable Biochemical Traits in Sisters with Polycystic Ovaries
- Polycystic Ovary Syndrome: Diagnosis and Treatment
- Wnt signaling induces epithelial differentiation during cutaneous wound healing
- Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome
- How to diagnose a lipodystrophy syndrome
- Mixed “Antiandrogenic” Chemicals at Low Individual Doses Produce Reproductive Tract Malformations in the Male Rat